Wikipedia:WikiProject Chemicals/Chembox validation/VerifiedDataSandbox and Adipiodone: Difference between pages
Appearance
(Difference between pages)
Content deleted Content added
Saving copy of the {{drugbox}} taken from revid 456550291 of page Adipiodone for the Chem/Drugbox validation project (updated: ''). |
→References: Fixed spacing between stub template and category templates. |
||
Line 1: | Line 1: | ||
{{Short description|Chemical compound}} |
|||
{{ambox | text = This page contains a copy of the infobox ({{tl|drugbox}}) taken from revid [{{fullurl:Adipiodone|oldid=456550291}} 456550291] of page [[Adipiodone]] with values updated to verified values.}} |
|||
{{Distinguish|Adipiplon}} |
|||
{{Drugbox |
{{Drugbox |
||
⚫ | |||
| Verifiedfields = changed |
|||
| Watchedfields = changed |
|||
⚫ | |||
| IUPAC_name = 3-{5-[(3-carboxy-2,4,6-triiodophenyl)carbamoyl]pentanamido}-2,4,6-triiodobenzoic acid |
| IUPAC_name = 3-{5-[(3-carboxy-2,4,6-triiodophenyl)carbamoyl]pentanamido}-2,4,6-triiodobenzoic acid |
||
| image = Adipiodone.png |
| image = Adipiodone.png |
||
| drug_name = Iodipamide |
|||
<!--Clinical data--> |
<!--Clinical data--> |
||
| tradename = |
| tradename = Cholografin, Biligrafin |
||
| Drugs.com = |
| Drugs.com = |
||
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> |
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> |
||
| pregnancy_US = <!-- A / B / C / D / X --> |
| pregnancy_US = <!-- A / B / C / D / X --> |
||
| pregnancy_category = |
| pregnancy_category = |
||
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled--> |
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled--> |
||
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII --> |
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII --> |
||
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C --> |
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C --> |
||
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V --> |
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V --> |
||
| legal_status = |
| legal_status = Rx-only |
||
| routes_of_administration = |
| routes_of_administration = |
||
<!--Pharmacokinetic data--> |
<!--Pharmacokinetic data--> |
||
| bioavailability = |
| bioavailability = |
||
| protein_bound = |
| protein_bound = |
||
| metabolism = |
| metabolism = |
||
| elimination_half-life = |
| elimination_half-life = |
||
| excretion = |
| excretion = |
||
<!--Identifiers--> |
<!--Identifiers--> |
||
| IUPHAR_ligand = 7400 |
|||
| CASNo_Ref = {{cascite|??|??}} |
|||
| CAS_number_Ref = {{cascite|correct|??}} |
| CAS_number_Ref = {{cascite|correct|??}} |
||
| CAS_number = 606-17-7 |
| CAS_number = 606-17-7 |
||
Line 41: | Line 36: | ||
| UNII_Ref = {{fdacite|correct|FDA}} |
| UNII_Ref = {{fdacite|correct|FDA}} |
||
| UNII = TKQ858A3VW |
| UNII = TKQ858A3VW |
||
| KEGG_Ref = {{keggcite| |
| KEGG_Ref = {{keggcite|correct|kegg}} |
||
| KEGG = D01774 |
| KEGG = D01774 |
||
| ChEBI = 31176 |
|||
| ChEMBL_Ref = {{ebicite|correct|EBI}} |
| ChEMBL_Ref = {{ebicite|correct|EBI}} |
||
| ChEMBL = 1165268 |
| ChEMBL = 1165268 |
||
<!--Chemical data--> |
<!--Chemical data--> |
||
| C=20 | H=14 |
| C=20 | H=14 |
||
| I=6 | N=2 |
|||
| O=6 |
|||
| molecular_weight = 1139.76 g/mol |
|||
| smiles = O=C(Nc1c(I)c(c(I)cc1I)C(=O)O)CCCCC(=O)Nc2c(I)c(C(=O)O)c(I)cc2I |
| smiles = O=C(Nc1c(I)c(c(I)cc1I)C(=O)O)CCCCC(=O)Nc2c(I)c(C(=O)O)c(I)cc2I |
||
| InChI = 1/C20H14I6N2O6/c21-7-5-9(23)17(15(25)13(7)19(31)32)27-11(29)3-1-2-4-12(30)28-18-10(24)6-8(22)14(16(18)26)20(33)34/h5-6H,1-4H2,(H,27,29)(H,28,30)(H,31,32)(H,33,34) |
|||
| InChIKey = FFINMCNLQNTKLU-UHFFFAOYAL |
|||
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
||
| StdInChI = 1S/C20H14I6N2O6/c21-7-5-9(23)17(15(25)13(7)19(31)32)27-11(29)3-1-2-4-12(30)28-18-10(24)6-8(22)14(16(18)26)20(33)34/h5-6H,1-4H2,(H,27,29)(H,28,30)(H,31,32)(H,33,34) |
| StdInChI = 1S/C20H14I6N2O6/c21-7-5-9(23)17(15(25)13(7)19(31)32)27-11(29)3-1-2-4-12(30)28-18-10(24)6-8(22)14(16(18)26)20(33)34/h5-6H,1-4H2,(H,27,29)(H,28,30)(H,31,32)(H,33,34) |
||
Line 58: | Line 52: | ||
| synonyms = <small>3-<nowiki>[[</nowiki>6-[(3-Carboxy-2,4,6-triiodophenyl)amino]-6-oxohexanoyl]amino]-2,4,6-triiodobenzoic acid </small> |
| synonyms = <small>3-<nowiki>[[</nowiki>6-[(3-Carboxy-2,4,6-triiodophenyl)amino]-6-oxohexanoyl]amino]-2,4,6-triiodobenzoic acid </small> |
||
}} |
}} |
||
'''Adipiodone''' ([[International Nonproprietary Name|INN]], or '''iodipamide'''; trade names '''Cholografin''' and '''Biligrafin''') is a pharmaceutical drug used as a [[radiocontrast agent]] in [[X-ray imaging]]. It was introduced in the 1950s.<ref>{{cite journal | vauthors = Hastings-James R, Glazebrook AJ | title = Cholografin | journal = Canadian Medical Association Journal | volume = 72 | issue = 8 | pages = 561–5 | date = April 1955 | pmid = 14364399 | pmc = 1825662 }}</ref><ref>{{cite journal | vauthors = Dilger SK, Nelson N, Venkatesh SK, Ehman EC, Fidler JL, Fletcher JG, McCollough CH, Yu L | display-authors = 6 | title = Computed Tomography Cholangiography Using the Magnetic Resonance Contrast Agent Gadoxetate Disodium: A Phantom Study | journal = Investigative Radiology | volume = 54 | issue = 9 | pages = 572–579 | date = September 2019 | pmid = 31261292 | doi = 10.1097/RLI.0000000000000580 | s2cid = 195772743 }}</ref> |
|||
== References == |
|||
{{reflist}} |
|||
{{Contrast media}} |
|||
[[Category:Radiocontrast agents]] |
|||
[[Category:Iodobenzene derivatives]] |
|||
[[Category:Benzoic acids]] |
|||
[[Category:Anilides]] |
|||
{{pharmacology-stub}} |